Report ID: SQSG35J2007
Report ID:
SQSG35J2007 |
Region:
Global |
Published Date: February, 2024
Pages:
165
|
Tables:
67 |
Figures:
75
The global home infusion therapy market in North America was valued at US$ 16.90 billion in 2021, as a result of the region's high uptake of the therapy and the presence of major companies. Additionally, a rising number of patients choosing infusion therapy at home is probably going to boost the industry in the area.
The market in Europe is anticipated to expand at a large rate due to the region's growing elderly population, rising chronic disease burden, and a growing number of government and industry initiatives supporting home infusion therapy.
During the forecast period, the market in Asia Pacific is anticipated to increase significantly and post the highest CAGR. This is attributable to both the surge in the use of cutting-edge technologies and the rising awareness of this treatment, which is used to treat a variety of chronic conditions. Additionally, the market in Asia Pacific is anticipated to grow during the projected period due to the rising prevalence of cancer, diabetes, and other long-term chronic diseases as well as an increase in the patient pool.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONHome Infusion Therapy Market size was valued at USD 43.35 billion in 2019 and is poised to grow from USD 45.41 billion in 2023 to USD 65.2 billion by 2031, growing at a CAGR of 4.63% in the forecast period (2024-2031).
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQSG35J2007